Condition: Inflammatory Bowel Diseases · Crohn Disease (CD) · Ulcerative Colitis (UC) · Sponsor: Pontificia Universidad Catolica de Chile
The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.
This description comes directly from the study's public registry record.
Cristian Hernández-Rocha, MD · 56-22-3543822 · caherna4@uc.cl
Manuel Álvarez-Lobos, MD · 56-22-3543822 · manalvarezl@gmail.com
Always discuss trial participation with your own doctor first.
| Pontificia Universidad Catolica of Chile | Santiago, Chile | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06756100